BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Filipe MI, Potet F, Bogomoletz WV, Dawson PA, Fabiani B, Chauveinc P, Fenzy A, Gazzard B, Goldfain D, Zeegen R. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985;26:1319-26. [PMID: 4085908 DOI: 10.1136/gut.26.12.1319] [Cited by in Crossref: 138] [Cited by in F6Publishing: 159] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Kanemitsu T, Uedo N, Ono T, Nimura S, Hasegawa R, Imamura K, Ohtsu K, Ono Y, Miyaoka M, Ueki T, Tanabe H, Ohta A, Iwashita A, Yao K. Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia. J Gastroenterol Hepatol 2023;38:94-102. [PMID: 36268636 DOI: 10.1111/jgh.16034] [Reference Citation Analysis]
2 Gao R, Zhang X, Chen X, Chen X, Pan D, Jin L, Lin Y, Zheng H, Yu X, Chen X. Clinical and pathological analysis of intestinal metaplasia and intraepithelial neoplasia of gastric mucosa: intestinal metaplasia inhibits the progression of intraepithelial neoplasia.. [DOI: 10.21203/rs.3.rs-2011421/v1] [Reference Citation Analysis]
3 Jaroenlapnopparat A, Bhatia K, Coban S. Inflammation and Gastric Cancer. Diseases 2022;10:35. [DOI: 10.3390/diseases10030035] [Reference Citation Analysis]
4 Koulis A, Di Costanzo N, Mitchell C, Lade S, Goode D, Busuttil RA, Boussioutas A. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia. BMC Gastroenterol 2022;22:197. [PMID: 35448971 DOI: 10.1186/s12876-022-02268-z] [Reference Citation Analysis]
5 Brown JW, Das KK, Kalas V, Das KM, Mills JC. mAb Das-1 recognizes 3'-Sulfated Lewis A/C, which is aberrantly expressed during metaplastic and oncogenic transformation of several gastrointestinal Epithelia. PLoS One 2021;16:e0261082. [PMID: 34910746 DOI: 10.1371/journal.pone.0261082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Koulis A, Busuttil RA, Boussioutas A. Premalignant lesions of the stomach and management of early neoplastic lesions. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00013-7] [Reference Citation Analysis]
8 Bamba CCA, Ngone GM, Salamata D, Polèle FM, Aïssé TM, Gnagna D, Louise BM, Daouda D, Mouhamadou M. Gastritis: Sociodemographic, Clinical, Endoscopic and Histological Aspects, about 593 Cases at the Digestive Endoscopy Unit of the General Hospital Idrissa Pouye. OJGas 2021;11:184-193. [DOI: 10.4236/ojgas.2021.1110019] [Reference Citation Analysis]
9 Ma L, Cao Y, Hu JJ, Chu ML. Casein kinase 2 interacting protein 1 positively regulates caudal-related homeobox 1 in intestinal-type gastric cancer. Chin Med J (Engl) 2020;133:154-64. [PMID: 31868807 DOI: 10.1097/CM9.0000000000000604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Gut Liver. 2019;13:596-603. [PMID: 31394893 DOI: 10.5009/gnl19181] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
11 Shah SC, Gawron AJ, Mustafa RA, Piazuelo MB. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Gastroenterology 2020;158:745-50. [PMID: 31887261 DOI: 10.1053/j.gastro.2019.12.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
12 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
13 Rotondo R, Rizzolio F, Perin T, Berretta M, Zanconati F, Giordano A, Canzonieri V. Pathological Diagnosis and Classification of Gastric Epithelial Tumours. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Graham DY, Zou WY. Guilt by association: intestinal metaplasia does not progress to gastric cancer. Curr Opin Gastroenterol 2018;34:458-64. [PMID: 30138135 DOI: 10.1097/MOG.0000000000000472] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
15 Camacho-Gomez SM, Bernieh A, Saad AG, Tipnis NA. Non-Helicobacter pylori Gastric Intestinal Metaplasia in Children: A Series of Cases and Review of the Literature. Case Rep Gastrointest Med 2018;2018:5930415. [PMID: 29850294 DOI: 10.1155/2018/5930415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
17 Olmez S, Aslan M, Erten R, Sayar S, Bayram I. The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes. Gastroenterol Res Pract. 2015;2015:434039. [PMID: 26635875 DOI: 10.1155/2015/434039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
18 Busuttil RA, Zapparoli GV, Haupt S, Fennell C, Wong SQ, Pang JM, Takeno EA, Mitchell C, Di Costanzo N, Fox S, Haupt Y, Dobrovic A, Boussioutas A. Role of p53 in the progression of gastric cancer. Oncotarget. 2014;5:12016-12026. [PMID: 25427447 DOI: 10.18632/oncotarget.2434] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
19 Compare D, Rocco A, Nardone G. Screening for and surveillance of gastric cancer. World J Gastroenterol 2014; 20(38): 13681-13691 [PMID: 25320506 DOI: 10.3748/wjg.v20.i38.13681] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
20 Dixon MF. Pathology of Gastritis and Peptic Ulceration. Helicobacter pylori 2014. [DOI: 10.1128/9781555818005.ch38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Mandal PK, Chakrabarti S, Ray A, Chattopadhyay B, Das S. Mucin histochemistry of stomach in metaplasia and adenocarcinoma: An observation. Indian J Med Paediatr Oncol 2013;34:229-33. [PMID: 24604948 DOI: 10.4103/0971-5851.125232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
22 Chatelain D, Attencourt C, Flejou J. Les classifications des gastrites: mise au point. Revue Francophone des Laboratoires 2014;2014:31-40. [DOI: 10.1016/s1773-035x(14)72313-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Squire JM, Guerreiro MJ, Sidebotham RL, Reis CA, Wiseman J, Luther PK. Quantitative MUC5AC and MUC6 mucin estimations in gastric mucus by a least-squares minimization method. Analytical Biochemistry 2013;439:204-11. [DOI: 10.1016/j.ab.2013.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am 2013;42:261-84. [PMID: 23639640 DOI: 10.1016/j.gtc.2013.01.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 9.9] [Reference Citation Analysis]
25 Okamoto N, Kawachi H, Yoshida T, Kitagaki K, Sekine M, Kojima K, Kawano T, Eishi Y. "Crawling-type" adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma. Gastric Cancer 2013;16:220-32. [PMID: 22865191 DOI: 10.1007/s10120-012-0173-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
26 Li Y, Chang X, Zhou W, Xiao Y, Nakatsuka LN, Chen J, Lauwers GY. Gastric intestinal metaplasia with basal gland atypia: a morphological and biologic evaluation in a large Chinese cohort. Human Pathology 2013;44:578-90. [DOI: 10.1016/j.humpath.2012.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ryu KH, Shim KN, Jung SA, Yoo K, Joo YH, Lee JH. Significance of preoperative tissue levels of vascular-endothelial cadherin, liver-intestine cadherin and vascular endothelial growth factor in gastric cancer. Korean J Gastroenterol. 2012;60:229-241. [PMID: 23089909 DOI: 10.4166/kjg.2012.60.4.229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
28 González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133:1023-1032. [PMID: 23280711 DOI: 10.1002/ijc.28003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
29 El-zimaity H, Riddell RH. Inflammatory Disorders of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy, European Helicobacter Study Group, European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 442] [Cited by in F6Publishing: 470] [Article Influence: 40.2] [Reference Citation Analysis]
32 Dinis-ribeiro M, Areia M, de Vries AC, Marcos-pinto R, Monteiro-soares M, O’connor A, Pereira C, Pimentel-nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-budnik T, Megraud F, Miki K, O’morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; on behalf of MAPS Participants. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46. [DOI: 10.1007/s00428-011-1177-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 91] [Article Influence: 4.9] [Reference Citation Analysis]
33 Stairs DB, Kong J, Lynch JP. Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia. Prog Mol Biol Transl Sci. 2010;96:231-270. [PMID: 21075347 DOI: 10.1016/b978-0-12-381280-3.00010-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
34 Kang JM, Lee BH, Kim N, Lee HS, Lee HE, Park JH, Kim JS, Jung HC, Song IS. CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci 2011;26:647-53. [PMID: 21532856 DOI: 10.3346/jkms.2011.26.5.647] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
35 Rugge M, Fassan M, Pizzi M, Pennelli G, Nitti D, Farinati F. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol. 2011;42:1539-1544. [PMID: 21481917 DOI: 10.1016/j.humpath.2010.12.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
36 Wright NA. Stem Cells in Intraepithelial Neoplasia. Pre-Invasive Disease: Pathogenesis and Clinical Management 2011. [DOI: 10.1007/978-1-4419-6694-0_1] [Reference Citation Analysis]
37 Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K, Murawaki Y. Premalignant lesions in gastric cancer. Clin J Gastroenterol 2010;3:6-12. [PMID: 26189899 DOI: 10.1007/s12328-009-0130-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
38 Sun Y, Li Z, Feng G, Li J. Long-term follow-up study on gastric intestinal metaplasia subtype and its relation to expression of P53, Bcl-2 and PCNA. Chin J Cancer Res 2009;21:272-277. [DOI: 10.1007/s11670-009-0272-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Jin B, Wang X, Jin Y, Xia W, Chen B, Liu L, Chen Z, Hong L, Du W, Yan K. Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. Cancer Invest. 2009;27:227-233. [PMID: 19235597 DOI: 10.1080/07357900802175609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
40 Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol 2009;24:193-201. [PMID: 19215332 DOI: 10.1111/j.1440-1746.2008.05774.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
41 Wang XG, Zhang Z, Sun LP, Yuan Y. Relationship between the expression of CDX2 and different types of gastric intestinal metaplasia. Shijie Huaren Xiaohua Zazhi 2009; 17(1): 86-89 [DOI: 10.11569/wcjd.v17.i1.86] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Kang KP, Lee HS, Kim N, Kang HM, Park YS, Lee DH, Choe G, Kim JS, Jung HC, Song IS. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol 2009;24:140-8. [PMID: 18713298 DOI: 10.1111/j.1440-1746.2008.05546.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
43 Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Omura N, Mitsumori N, Ohmura M, Yanaga K. Pre-pyloric site gastric cancer after pylorus-preserving gastrectomy (PPG): a case report. Int J Surg 2008;6:e20-3. [PMID: 19059127 DOI: 10.1016/j.ijsu.2006.09.009] [Reference Citation Analysis]
44 Shiotani A, Kamada T, Yamanaka Y, Manabe N, Kusunoki H, Hata J, Haruma K. Sonic hedgehog and CDX2 expression in the stomach. J Gastroenterol Hepatol 2008;23 Suppl 2:S161-6. [PMID: 19120891 DOI: 10.1111/j.1440-1746.2008.05406.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ibrişim D, Cevikbaş U, Akyüz F, Poturoğlu S, Ahishali E, Güllüoğlu M, Demir K, Beşişik F, Boztaş G, Ozdil S, Cakaloğlu Y, Mungan Z, Okten A, Kaymakoğlu S. Intestinal metaplasia in portal hypertensive gastropathy: a frequent pathology. Eur J Gastroenterol Hepatol 2008;20:874-80. [PMID: 18794601 DOI: 10.1097/MEG.0b013e3282fc7380] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
46 Mastracci L, Bruno S, Spaggiari P, Ceppa P, Fiocca R. The impact of biopsy number and site on the accuracy of intestinal metaplasia detection in the stomach A morphometric study based on virtual biopsies. Dig Liver Dis 2008;40:632-40. [PMID: 18406219 DOI: 10.1016/j.dld.2008.02.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
47 Eriksson NK, Kärkkäinen PA, Färkkilä MA, Arkkila PE. Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 2008;40:355-60. [PMID: 18291729 DOI: 10.1016/j.dld.2007.12.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
48 Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod Pathol 2007;20:1286-97. [PMID: 17906616 DOI: 10.1038/modpathol.3800968] [Cited by in Crossref: 67] [Cited by in F6Publishing: 77] [Article Influence: 4.2] [Reference Citation Analysis]
49 Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer. 2007;121:1182-1189. [PMID: 17520681 DOI: 10.1002/ijc.22835] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
50 Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-72. [PMID: 17681184 DOI: 10.1053/j.gastro.2007.06.026] [Cited by in Crossref: 467] [Cited by in F6Publishing: 494] [Article Influence: 29.2] [Reference Citation Analysis]
51 Lee HW, Yang DH, Kim HK, Lee BH, Choi KC, Choi YH, Park YE. Expression of MUC2 in gastric carcinomas and background mucosae. J Gastroenterol Hepatol 2007;22:1336-43. [PMID: 17559374 DOI: 10.1111/j.1440-1746.2007.04939.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
52 Giraud AS. Metaplasia as a premalignant pathology in the stomach. Gastroenterology 2007;132:2053-6. [PMID: 17484897 DOI: 10.1053/j.gastro.2007.03.074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
53 Tsukamoto T, Mizoshita T, Tatematsu M. Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer 2006;9:156-66. [PMID: 16952033 DOI: 10.1007/s10120-006-0375-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
54 Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther 2006;24 Suppl 4:71-80. [PMID: 17209848 DOI: 10.1111/j.1365-2036.2006.00028.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
55 Shiotani A, Haruma K, Uedo N, Iishi H, Ishihara R, Tatsuta M, Kumamoto M, Nakae Y, Ishiguro S, Graham DY. Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer. Virchows Arch. 2006;449:652-659. [PMID: 17058096 DOI: 10.1007/s00428-006-0300-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
56 El-Zimaity HM. Gastric atrophy, diagnosing and staging. World J Gastroenterol 2006; 12(36): 5757-5762 [PMID: 17007038 DOI: 10.3748/wjg.v12.i36.5757] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
57 Genta RM, Rugge M. Assessing risks for gastric cancer: New tools for pathologists. World J Gastroenterol 2006; 12(35): 5622-5627 [PMID: 17007013 DOI: 10.3748/wjg.v12.i35.5622] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
58 Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther Symp Series 2006;2:71-80. [DOI: 10.1111/j.1746-6342.2006.00028.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
59 Li H, Ning P, Yuan Y. Contrastive study of the tissue expression and serum concentration of pepsinogen C in gastric mucosa diseases. Chin J Cancer Res 2006;18:8-11. [DOI: 10.1007/s11670-006-0008-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Tanaka H, Tsukamoto T, Mizoshita T, Inada K, Ogasawara N, Cao X, Kato S, Joh T, Tatematsu M. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach. Virchows Arch 2005;447:806-15. [PMID: 16088401 DOI: 10.1007/s00428-005-0040-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
61 Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology. 2005;46:649-658. [PMID: 15910596 DOI: 10.1111/j.1365-2559.2005.02170.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 4.3] [Reference Citation Analysis]
62 Sun Y, Li JY, He JS, Zhou LX, Chen K. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology. 2005;46:505-514. [PMID: 15842632 DOI: 10.1111/j.1365-2559.2005.02111.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
63 Ning PF, Liu HJ, Yuan Y. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol 2005; 11(17): 2545-2548 [PMID: 15849808 DOI: 10.3748/wjg.v11.i17.2545] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
64 Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Merchant JL. Evidence that loss of sonic hedgehog is an indicator of Helicobater pylori-induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol 2005;100:581-7. [PMID: 15743355 DOI: 10.1111/j.1572-0241.2005.41001.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
65 Niwa T, Ikehara Y, Nakanishi H, Tanaka H, Inada K, Tsukamoto T, Ichinose M, Tatematsu M. Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem 2005;53:75-85. [PMID: 15637340 DOI: 10.1177/002215540505300109] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
66 Ning PF, Liu HJ, Yuan Y. Expression of pepsinogen C in Helicobacter pylori-associated gastric lesions. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1089-1091 [DOI: 10.11569/wcjd.v12.i5.1089] [Reference Citation Analysis]
67 Mitsuhashi A, Yamazawa K, Nagai Y, Tanaka N, Matsui H, Sekiya S. Correlation between MUC5AC expression and the prognosis of patients with adenocarcinoma of the uterine cervix. Ann Surg Oncol 2004;11:40-4. [PMID: 14699032 DOI: 10.1007/BF02524344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
68 Guo D, Ning P, Yuan Y. Antigen MG7 in gastric cancer and gastric precancerous lesions. Chin J Cancer Res 2004;16:1-4. [DOI: 10.1007/bf02974857] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Aihara R, Mochiki E, Kamiyama Y, Kamimura H, Asao T, Kuwano H. Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: its relationship with the clinicopathologic factors. Dig Dis Sci 2004;49:417-24. [PMID: 15139491 DOI: 10.1023/b:ddas.0000020496.98711.14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
70 Tsukamoto T, Inada K, Tanaka H, Mizoshita T, Mihara M, Ushijima T, Yamamura Y, Nakamura S, Tatematsu M. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol. 2004;130:135-145. [PMID: 14655050 DOI: 10.1007/s00432-003-0519-6] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 5.2] [Reference Citation Analysis]
71 Bodger K, Campbell F, Rhodes JM. Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope. J Clin Pathol 2003;56:703-8. [PMID: 12944557 DOI: 10.1136/jcp.56.9.703] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
72 Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 2003; 9(6): 1156-1164 [PMID: 12800215 DOI: 10.3748/wjg.v9.i6.1156] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 43] [Article Influence: 1.9] [Reference Citation Analysis]
73 Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003;36:S37-43; discussion S61-2. [PMID: 12702964 DOI: 10.1097/00004836-200305001-00007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
74 Morales CP, Spechler SJ. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers. Am J Gastroenterol 2003;98:759-62. [PMID: 12738452 DOI: 10.1111/j.1572-0241.2003.07393.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kawachi H, Takizawa T, Eishi Y, Shimizu S, Kumagai J, Funata N, Koike M. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol 2003;199:436-46. [PMID: 12635134 DOI: 10.1002/path.1323] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
76 Oksanen A, Sipponen P, Karttunen R, Rautelin H. Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection. Gut 2003;52:194-8. [PMID: 12524399 DOI: 10.1136/gut.52.2.194] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
77 El-zimaity H. Multifocal Atrophic Gastritis (MAG) does not exist: new finding based on sectioning the entire stomach. Helicobactor pylori 2003. [DOI: 10.1007/978-94-017-1763-2_13] [Reference Citation Analysis]
78 Guo DL, Dong M, Wang L, Sun LP, Yuan Y. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori-associated gastric diseases. World J Gastroenterol 2002; 8(6): 1009-1013 [PMID: 12439915 DOI: 10.3748/wjg.v8.i6.1009] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
79 El-Zimaity HM, Ota H, Graham DY, Akamatsu T, Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 2002;94:1428-36. [PMID: 11920498 DOI: 10.1002/cncr.10375] [Cited by in Crossref: 128] [Cited by in F6Publishing: 133] [Article Influence: 6.1] [Reference Citation Analysis]
80 Canöz O, Belenli O, Patiroglu TE. General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors. Pathol Oncol Res 2002;8:262-9. [PMID: 12579213 DOI: 10.1007/BF03036742] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
81 El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 2001;54:679-83. [PMID: 11533073 DOI: 10.1136/jcp.54.9.679] [Cited by in Crossref: 99] [Cited by in F6Publishing: 108] [Article Influence: 4.5] [Reference Citation Analysis]
82 Conchillo JM, Houben G, de Bruïne A, Stockbrügger R. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? Eur J Cancer Prev 2001;10:307-12. [PMID: 11535872 DOI: 10.1097/00008469-200108000-00003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
83 Grötzinger C, Kneifel J, Patschan D, Schnoy N, Anagnostopoulos I, Faiss S, Tauber R, Wiedenmann B, Gessner R. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut 2001;49:73-81. [PMID: 11413113 DOI: 10.1136/gut.49.1.73] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 3.3] [Reference Citation Analysis]
84 Jass JR, Walsh MD. Altered mucin expression in the gastrointestinal tract: a review. J Cell Mol Med 2001;5:327-51. [PMID: 12067494 DOI: 10.1111/j.1582-4934.2001.tb00169.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 64] [Article Influence: 2.5] [Reference Citation Analysis]
85 Nomura S, Tatemichi M, Kaminishi M, Esumi H. A novel method for detecting single glandular intestinal metaplasia in the mucosal surface of the fixed stomach using methylene blue. Jpn J Cancer Res 2001;92:659-65. [PMID: 11429055 DOI: 10.1111/j.1349-7006.2001.tb01145.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
86 Genta RM, Rugge M. Review article: pre-neoplastic states of the gastric mucosa--a practical approach for the perplexed clinician. Aliment Pharmacol Ther 2001;15 Suppl 1:43-50. [PMID: 11488661 DOI: 10.1046/j.1365-2036.2001.00110.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
87 Russo A, Maconi G, Spinelli P, Felice GD, Eboli M, Andreola S, Ravagnani F, Settesoldi D, Ferrari D, Lombardo C, Bertario L. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol 2001;96:1402-8. [PMID: 11374674 DOI: 10.1111/j.1572-0241.2001.03773.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
88 El-Zimaity HMT, Gutierrez O, Kim JG, Akamatsu T, Gürer IE, Simjee AE, Graham DY. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001;96:666-72. [PMID: 11280531 DOI: 10.1111/j.1572-0241.2001.03601.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
89 Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol 2001;115:224-34. [PMID: 11211611 DOI: 10.1309/VLF5-UCNH-XQM2-X410] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
90 Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology 2000;37:513-22. [PMID: 11122433 DOI: 10.1046/j.1365-2559.2000.01008.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis]
91 Satoh K. Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan. Gastroenterol Clin North Am 2000;29:829-35. [PMID: 11190067 DOI: 10.1016/s0889-8553(05)70150-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
92 Zullo A, Rinaldi V, Hassan C, Diana F, Winn S, Castagna G, Attili AF. Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study. Aliment Pharmacol Ther 2000;14:1303-9. [PMID: 11012475 DOI: 10.1046/j.1365-2036.2000.00841.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 1.6] [Reference Citation Analysis]
93 Spechler SJ. Barrett's oesophagus: diagnosis and management. Baillieres Best Pract Res Clin Gastroenterol 2000;14:857-79. [PMID: 11003814 DOI: 10.1053/bega.2000.0129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
94 Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000;95:1431-8. [PMID: 10894575 DOI: 10.1111/j.1572-0241.2000.02074.x] [Cited by in Crossref: 183] [Cited by in F6Publishing: 192] [Article Influence: 8.0] [Reference Citation Analysis]
95 Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999;1473:67-95. [PMID: 10580130 DOI: 10.1016/s0304-4165(99)00170-1] [Cited by in Crossref: 420] [Cited by in F6Publishing: 435] [Article Influence: 17.5] [Reference Citation Analysis]
96 Bowrey DJ, Clark GW, Williams GT. Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999;45:798-803. [PMID: 10562575 DOI: 10.1136/gut.45.6.798] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 1.4] [Reference Citation Analysis]
97 Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology 1999;35:517-24. [PMID: 10583575 DOI: 10.1046/j.1365-2559.1999.00791.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 2.1] [Reference Citation Analysis]
98 Voutilainen M, Färkkilä M, Juhola M, Mecklin JP, Sipponen P. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut 1999;45:644-8. [PMID: 10517897 DOI: 10.1136/gut.45.5.644] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 1.6] [Reference Citation Analysis]
99 Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, Frati L, Luzi G. Gastric pathology in patients with common variable immunodeficiency. Gut 1999;45:77-81. [PMID: 10369708 DOI: 10.1136/gut.45.1.77] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 3.9] [Reference Citation Analysis]
100 Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 1999;30:826-32. [PMID: 10414502 DOI: 10.1016/s0046-8177(99)90144-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 2.5] [Reference Citation Analysis]
101 Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999;117:218-28. [PMID: 10381931 DOI: 10.1016/s0016-5085(99)70571-8] [Cited by in Crossref: 131] [Cited by in F6Publishing: 130] [Article Influence: 5.5] [Reference Citation Analysis]
102 Lynch DA, Mapstone NP, Clarke AM, Jackson P, Moayyedi P, Dixon MF, Quirke P, Axon AT. Correlation between epithelial cell proliferation and histological grading in gastric mucosa. J Clin Pathol 1999;52:367-71. [PMID: 10560358 DOI: 10.1136/jcp.52.5.367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
103 Sasaki I, Yao T, Nawata H, Tsuneyoshi M. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer 1999;85:1719-29. [DOI: 10.1002/(sici)1097-0142(19990415)85:8<1719::aid-cncr11>3.0.co;2-v] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
104 El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 1999;30:72-7. [PMID: 9923930 DOI: 10.1016/s0046-8177(99)90303-9] [Cited by in Crossref: 87] [Cited by in F6Publishing: 124] [Article Influence: 3.6] [Reference Citation Analysis]
105 Fraser AG, Peng SL, Jass JR. Intestinal metaplasia subtypes and Helicobacter pylori infection: a comparison of ethnic groups in New Zealand. J Gastroenterol Hepatol 1998;13:560-5. [PMID: 9715396 DOI: 10.1111/j.1440-1746.1998.tb00690.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
106 Nomura S, Kaminishi M, Sugiyama K, Oohara T, Esumi H. Clonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphism. Gut 1998;42:663-8. [PMID: 9659161 DOI: 10.1136/gut.42.5.663] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
107 Solcia E, Villani L, Trespi E, Broglia F, Colla C, Luinetti O, Mastracci L, Tinelli C, Fiocca R. Cardia mucosa gastritis(carditis):pathogenesis,correlation with gastritis of other sites and clinicopathological relevance. Helicobacter pylori 1998. [DOI: 10.1007/978-94-011-4882-5_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
108 Dixon MF. Atrophy, metaplasia and dysplasia - a risk for gastric cancer: are they reversible? Helicobacter pylori 1998. [DOI: 10.1007/978-94-011-4882-5_36] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
109 Inada K, Nakanishi H, Fujimitsu Y, Shimizu N, Ichinose M, Miki K, Nakamura S, Tatematsu M. Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol Int 1997;47:831-41. [PMID: 9503464 DOI: 10.1111/j.1440-1827.1997.tb03714.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
110 Yanai H, Takada K, Shimizu N, Mizugaki Y, Tada M, Okita K. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol 1997;183:293-8. [PMID: 9422984 DOI: 10.1002/(SICI)1096-9896(199711)183:3<293::AID-PATH937>3.0.CO;2-C] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
111 Kubba AK, MacIntyre IM. Gastric cancer distal to the cardia--prevention or cure? Surg Oncol 1997;6:111-24. [PMID: 9436657 DOI: 10.1016/s0960-7404(97)00011-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
112 Miehlke S, Bayerdörffer E, Meining A, Stolte M, Malfertheiner P. Identifying persons at risk for gastric cancer? Helicobacter 1997;2 Suppl 1:S61-6. [PMID: 9432357 DOI: 10.1111/j.1523-5378.1997.06b12.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
113 Brockhausen I, Kuhns W. Glycosylation in Cancer and Oncogenic Transformation. Glycoproteins and Human Disease 1997. [DOI: 10.1007/978-3-662-21960-7_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
114 Zea-Iriarte WL, Sekine I, Itsuno M, Makiyama K, Naito S, Nakayama T, Nishisawa-Takano JE, Hattori T. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci 1996;41:377-86. [PMID: 8601386 DOI: 10.1007/BF02093832] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 2.6] [Reference Citation Analysis]
115 Owen DA. The morphology of gastritis. Yale J Biol Med 1996;69:51-60. [PMID: 9041689] [Reference Citation Analysis]
116 Demirturk L, Hulagu S, Altin M, Ucmakli E, Dumanhan L, Ozel M. Does staining gastric mucosa with methylene blue spraying method affect diagnosis of Helicobacter pylori? Gastrointest Endosc 1996;43:81. [PMID: 8903830 DOI: 10.1016/s0016-5107(96)70273-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
117 Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol 1994;17:153-80. [PMID: 7865137 DOI: 10.1016/1040-8428(94)90053-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 2.1] [Reference Citation Analysis]
118 Pascal RR. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Hum Pathol 1994;25:1160-71. [PMID: 7959660 DOI: 10.1016/0046-8177(94)90032-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 1.9] [Reference Citation Analysis]
119 Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol 1994;25:994-1005. [PMID: 7927322 DOI: 10.1016/0046-8177(94)90058-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 2.4] [Reference Citation Analysis]
120 Filipe MI, Muñoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Teuchmann S, Benz M, Prijon T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9. [PMID: 8168991 DOI: 10.1002/ijc.2910570306] [Cited by in Crossref: 298] [Cited by in F6Publishing: 313] [Article Influence: 10.3] [Reference Citation Analysis]
121 Lechago J, Correa P. Prolonged achlorhydria and gastric neoplasia: is there a causal relationship? Gastroenterology 1993;104:1554-7. [PMID: 8482469 DOI: 10.1016/0016-5085(93)90370-r] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis]
122 Tosi P, Filipe MI, Luzi P, Miracco C, Santopietro R, Lio R, Sforza V, Barbini P. Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry. J Pathol 1993;169:73-8. [PMID: 8433217 DOI: 10.1002/path.1711690112] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
123 Kato Y, Kitagawa T, Yanagisawa A, Kubo K, Utsude T, Hiratsuka H, Tamaki M, Sugano H. Site-dependent development of complete and incomplete intestinal metaplasia types in the human stomach. Jpn J Cancer Res. 1992;83:178-183. [PMID: 1372886 DOI: 10.1111/j.1349-7006.1992.tb00084.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
124 Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 1992;33:597-600. [PMID: 1612473 DOI: 10.1136/gut.33.5.597] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 1.8] [Reference Citation Analysis]
125 Torrado J, Correa P, Ruiz B, Bernardi P, Zavala D, Bara J. Lewis antigen alterations in gastric cancer precursors. Gastroenterology 1992;102:424-30. [PMID: 1732113 DOI: 10.1016/0016-5085(92)90086-e] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
126 Filipe MI. Borderline Lesions of the Gastric Epithelium: New Indicators of Cancer Risk and Clinical Implications. Progress in Surgical Pathology 1992. [DOI: 10.1007/978-3-662-09515-7_12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
127 Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci 1991;36:1529-36. [PMID: 19160603 DOI: 10.1007/BF01296393] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
128 Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991;32:1110-3. [PMID: 1955163 DOI: 10.1136/gut.32.10.1110] [Cited by in Crossref: 164] [Cited by in F6Publishing: 189] [Article Influence: 5.1] [Reference Citation Analysis]
129 Seery JP. A reinterpretation of the events in gastric carcinogenesis. Med Hypotheses 1991;35:179-81. [PMID: 1943860 DOI: 10.1016/0306-9877(91)90229-r] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
130 Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209-22. [PMID: 1912431 DOI: 10.1111/j.1440-1746.1991.tb01468.x] [Cited by in Crossref: 665] [Cited by in F6Publishing: 713] [Article Influence: 20.8] [Reference Citation Analysis]
131 Cunliffe WJ. The rationale for early postoperative intraperitoneal chemotherapy for gastric cancer. Cancer Treat Res 1991;55:143-59. [PMID: 1681854 DOI: 10.1007/978-1-4615-3882-0_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
132 C. Y. Tzen, M. Filipak, R. E. Scott. Metaplastic change in mesenchymal stem cells induced by activated ras oncogene. Am J Pathol 1990;137. [PMID: 2240160] [Reference Citation Analysis]
133 Murayama H, Kikuchi M, Enjoji M, Morita N, Haraguchi Y. Changes in gastric mucosa that antedate gastric carcinoma. Cancer 1990;66:2017-26. [PMID: 1699656 DOI: 10.1002/1097-0142(19901101)66:9<2017::aid-cncr2820660929>3.0.co;2-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
134 Torrado J, Blasco E, Gutierrez-Hoyos A, Cosme A, Lojendio M, Arenas JI. Lewis system alterations in gastric carcinogenesis. Cancer 1990;66:1769-74. [PMID: 2208033 DOI: 10.1002/1097-0142(19901015)66:8<1769::aid-cncr2820660822>3.0.co;2-q] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
135 Silva S, Filipe MI, Pinho A. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut 1990;31:1097-104. [PMID: 2083854 DOI: 10.1136/gut.31.10.1097] [Cited by in Crossref: 56] [Cited by in F6Publishing: 68] [Article Influence: 1.7] [Reference Citation Analysis]
136 Matsukuma A, Mori M, Enjoji M. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 1990;66:689-94. [PMID: 2386900 DOI: 10.1002/1097-0142(19900815)66:4<689::aid-cncr2820660417>3.0.co;2-f] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
137 Scott N, Lansdown M, Diament R, Rathbone B, Murday V, Wyatt JI, McMahon M, Dixon MF, Quirke P. Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet 1990;335:728. [PMID: 1969086 DOI: 10.1016/0140-6736(90)90845-v] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.2] [Reference Citation Analysis]
138 Falck VG, Novelli MR, Wright NA, Alexander N. Gastric dysplasia: inter-observer variation, sulphomucin staining and nucleolar organizer region counting. Histopathology 1990;16:141-9. [PMID: 2323735 DOI: 10.1111/j.1365-2559.1990.tb01082.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
139 Toshkov I, Kirev T. Mucin histochemistry of virus-induced duodenal adenomas in guinea fowl. J Cancer Res Clin Oncol 1990;116:38-44. [PMID: 2312604 DOI: 10.1007/BF01612638] [Reference Citation Analysis]
140 Sipponen P. Gastric dysplasia. Curr Top Pathol 1990;81:61-76. [PMID: 2407446 DOI: 10.1007/978-3-642-74662-8_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
141 Correa P. Prospects for Early Detection of Gastric Cancer and Precancerous Lesions. New Trends in Gastric Cancer 1990. [DOI: 10.1007/978-94-009-2167-2_6] [Reference Citation Analysis]
142 Sossai P, Cielo R, Barbazza R. Is intestinal metaplasia a risk for gastric carcinoma? Postgrad Med J 1989;65:604. [PMID: 2602266 DOI: 10.1136/pgmj.65.766.604] [Reference Citation Analysis]
143 Prat M, Medico E, Garrino C, Comoglio PM. Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5. Int J Cancer 1989;44:67-74. [PMID: 2473039 DOI: 10.1002/ijc.2910440113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
144 Hollands MJ, Filipe I, Edwards S, Brame K, Maisey M, Owen WJ. Clinical and histological sequelae of Roux-en-Y diversion. Br J Surg 1989;76:481-4. [PMID: 2736362 DOI: 10.1002/bjs.1800760518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
145 Newbold KM. Intestinal-type gastric carcinoma and colonic carcinoma: a common pathogenesis? Lancet 1989;1:131-3. [PMID: 2563049 DOI: 10.1016/s0140-6736(89)91145-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
146 Bogomoletz WV, Geboes K, Feydy P, Nasca S, Ectors N, Rigaud C. Mucin histochemistry of heterotopic gastric mucosa of the upper esophagus in adults: possible pathogenic implications. Hum Pathol 1988;19:1301-6. [PMID: 3181950 DOI: 10.1016/s0046-8177(88)80285-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 0.7] [Reference Citation Analysis]
147 O'Connor HJ, Riley SE, Axon AT, Dixon MF, Girling A, Garner RC. The mutagenic activity of gastric juice. Mutat Res 1988;206:103-13. [PMID: 3045533 DOI: 10.1016/0165-1218(88)90146-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
148 Rubio CA, Porwit A, Rodensjö M. Method to quantitate intestinal metaplasia of stomach by image analysis. J Clin Pathol 1988;41:799-801. [PMID: 3410974 DOI: 10.1136/jcp.41.7.799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
149 Bogomoletz WV. Apport de ľhistochimie des mucines à ľétude et au diagnostic des conditions et lésions précancéreuses de la muqueuse gastrique. Acta Endosc 1988;18:5-14. [DOI: 10.1007/bf02965010] [Reference Citation Analysis]
150 Filipe MI, Barbatis C, Sandey A, Ma J. Expression of intestinal mucin antigens in the gastric epithelium and its relationship with malignancy. Hum Pathol 1988;19:19-26. [PMID: 3275579 DOI: 10.1016/s0046-8177(88)80311-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 0.9] [Reference Citation Analysis]
151 Ramesar KC, Sanders DS, Hopwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J Clin Pathol 1987;40:1287-90. [PMID: 3693566 DOI: 10.1136/jcp.40.11.1287] [Cited by in Crossref: 46] [Cited by in F6Publishing: 55] [Article Influence: 1.3] [Reference Citation Analysis]
152 Bedossa P, Lemaigre G, Martin ED. Histochemical study of mucosubstances in carcinoma of gastric remnant. Cancer 1987;60:2224-7. [PMID: 3440232 DOI: 10.1002/1097-0142(19871101)60:9<2224::aid-cncr2820600920>3.0.co;2-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
153 Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986;10:1271-7. [PMID: 3817762 DOI: 10.1111/j.1365-2559.1986.tb02570.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 1.6] [Reference Citation Analysis]
154 Romagnoli P, Nardi F, Tonelli F, Bechi P. Histochemistry of small intestinal dysplasia in familial polyposis coli. Virchows Arch B Cell Pathol Incl Mol Pathol 1986;52:117-28. [PMID: 2878528 DOI: 10.1007/BF02889956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
155 Silva S, Filipe MI. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. Hum Pathol 1986;17:988-95. [PMID: 3759069 DOI: 10.1016/s0046-8177(86)80082-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 1.7] [Reference Citation Analysis]